Crossmark

Immune checkpoint inhibitors combined with chemotherapy vs chemotherapy alone in advanced or metastatic triple-negative breast cancer: a systematic review and random-effects meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s10238-026-02309-x

Published Online: 2026-09-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Valencia, Alberto https://orcid.org/0009-0001-8948-4798
Garcia, Sebastian

Tran, Katelyn https://orcid.org/0009-0003-4119-5190
Arredondo, Andre

Sweeney, Keith https://orcid.org/0000-0002-4214-8308
License Information

Text and Data Mining valid from 2026-09-12

Accepted Manuscript valid from 2026-09-12
More Information

Article History

Received: 11 August 2026

Accepted: 21 August 2026

First Online: 12 September 2026

Declarations

Conflicts of interest: No conflicts of interest.

Ethical Approval: Ethical approval was not required as this study used published data only.

Document is current

Any future updates will be listed below